| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.37 | 0.03 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.38 | 0.03 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.03 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.04 |